01 1Emcure Pharmaceuticals
01 1PALIPERIDONE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-10-21
Pay. Date : 2016-08-22
DMF Number : 30415
Submission : 2016-03-31
Status : Active
Type : II
20
Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PALIPERIDONE USP, with a corresponding US DMF Number 30415.
Remarkably, this DMF maintains an Active status since its submission on March 31, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 21, 2016, and payment made on August 22, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
